Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Beta Drugs IPO.
October 28, 2024 10:48:00 AM
Beta Drugs Ltd share price was up by 0.59% from the previous closing price of ?1,682.35. Who are peers of Beta Drugs Ltd? The peers of Beta Drugs Ltd are Sun Pharmaceuticals Industries Ltd ...
Published by : Business TodayNovember 11, 2024 7:10:00 PM
Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to ...
Published by : India InfolineNovember 5, 2024 8:50:00 PM
With experience in approved TGF-beta drugs Reblozyl and Winrevair, the company is developing drugs optimized for better efficacy and safety, the analyst tells investors in a research note.
Published by : NasdaqOctober 25, 2024 4:30:00 AM
Following the IPO, the company plans to spend $54 million to advance lead drug candidate SEP-786 through Phase 2 testing in hypoparathyroidism, according to the filing. The company also plans to ...
Published by : MedCity NewsSeptember 27, 2024 8:13:00 PM
What does Azelaprag do? It’s a weight loss drug that, the company hopes, will help manage and relieve obesity. Here’s what you need to know about BioAge’s IPO. BioAge Labs, Inc. is a ...
Published by : Fast Company on MSNSeptember 27, 2024 12:10:00 AM
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public offering (IPO) price on Thursday. The Richmond, California-based company set ...
Published by : MSNOctober 25, 2024 7:21:00 AM
Septerna now offering 16 mln shares vs 15.3 mln shares earlier Sets IPO price at $18 a share Drug developer backed by Goldman, Third Rock Ventures Listing follows a spate of biotech IPOs since ...
Published by : ReutersOctober 11, 2024 4:30:00 AM
Beta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines ...
Published by : MintThe issue of Beta Drugs Limited opens on Sep 29, 2017 and closes for subscription on Oct 04, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 85.
Beta Drugs Limited is entering in the capital market with an IPO of 229,600 Equity Shares of Rs 10 aggregating up to Rs 1.95 Cr. The price band for the issue has been fixed at Rs 85.
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The issue opens on Sep 29, 2017 and closes for subscription on Oct 4, 2017. The equity shares of the company to be list at NSE SME platform.
The Beta Drugs IPO is proposed to open on September 29, 2017. The IPO application ends on October 4, 2017.
Retail investors can apply in the retail or non-institutional investor category from September 29, 2017 to October 4, 2017. The Beta Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Beta Drugs IPO will open for subscription on September 29, 2017. The public issue will close on October 4, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
